Target intelligence / Profile preview

Hematopoietic stem cell niche (HSC niche)

Target
HSC niche
Molecular classification
Other (anatomical microenvironment; not a discrete molecule, but a collection of cell types and molecular components)
01

Overview

The hematopoietic stem cell niche refers to the specialized microenvironment in the bone marrow that maintains and regulates hematopoietic stem cells. It is composed of various stromal cells (osteoblasts, endothelial cells, mesenchymal stromal cells, perivascular cells), hematopoietic cells (megakaryocytes, macrophages, regulatory T-cells), and molecular cues (growth factors, cytokines, adhesion molecules). The niche governs the balance between HSC quiescence, self-renewal, proliferation, and differentiation, enabling lifelong blood cell production and immune function. Alterations in the niche can contribute to diseases such as leukemia and impact outcomes after stem cell transplantation. Unlike classical drug targets (e.g., receptors), the HSC niche is a complex, multicellular system rather than a distinct druggable entity. The hematopoietic stem cell niche is a biologically and clinically vital anatomical and functional concept, not a molecular therapeutic target. It functions as a regulatory microenvironment and is the focus of research into stem cell regulation, disease etiology, and transplantation, but "HSC niche" does not represent a discrete drug-targetable molecule or receptor.

Other names
bone marrow nicheHSC microenvironment
02

Mechanism of action

Not applicable to the niche directly; see note above regarding drugs acting on signaling pathways or cellular constituents within the niche

03

Biological functions

Support of hematopoietic stem cell self-renewal and survivalRegulation of stem cell quiescence and proliferationControl of stem cell migration, differentiation, and mobilizationMaintenance of blood and immune system homeostasis
04

Disease associations

Cancer (malignant transformation and leukemogenesis may involve niche abnormalities)Other (Aging, bone marrow failure syndromes, transplantation outcomes, immune disorders)
05

Safety considerations

Not applicable for the niche itself; safety concerns arise in therapies affecting niche components (e.g., altering microenvironment may impact engraftment or leukemogenesis)
06

Interacting drugs

None directly (however, drugs may act on molecular components or signals within the niche—such as CXCR4 antagonists—but not the niche itself)
07

Biomarkers

None specifically for the niche as a whole; molecular markers (such as SDF-1/CXCL12, VCAM1, CD146, or SLAM antigens) are used in the study of niche components

Beyond the preview

Go deeper on Hematopoietic stem cell niche (HSC niche).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoietic stem cell niche (HSC niche).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call